» Authors » P Rocha-Pereira

P Rocha-Pereira

Explore the profile of P Rocha-Pereira including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 365
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Coimbra S, Oliveira H, Rocha-Pereira P, Figueiredo A, Santos-Silva A
Br J Dermatol . 2016 Aug; 176(3):829-831. PMID: 27479860
No abstract available.
2.
Coimbra S, Oliveira H, Neuparth M, Proenca J, Figueiredo A, Rocha-Pereira P, et al.
Br J Dermatol . 2015 Jul; 174(2):414-6. PMID: 26148122
No abstract available.
3.
Sereno J, Vala H, Nunes S, Rocha-Pereira P, Carvalho E, Alves R, et al.
J Physiol Pharmacol . 2015 Apr; 66(2):285-99. PMID: 25903959
Side-effect minimization strategies to avoid serious side-effects of cyclosporine A (CsA), such as nephrotoxicity, have been mainly based on dose reduction and conversion to other putatively less nephrotoxic drugs, such...
4.
Fernandes J, Garrido P, Ribeiro S, Rocha-Pereira P, Bronze-da-Rocha E, Belo L, et al.
Biomed Res Int . 2015 Jan; 2014:421304. PMID: 25580431
Erythroid hypoplasia (EH) is a rare complication associated with recombinant human erythropoietin (rHuEPO) therapies, due to development of anti-rHuEPO antibodies; however, the underlying mechanisms remain poorly clarified. Our aim was...
5.
Martins F, Catarino C, Rocha-Pereira P, Reis F, Sameiro-Faria M, Miranda V, et al.
Br J Biomed Sci . 2014 Jul; 71(2):79-81. PMID: 24974683
No abstract available.
6.
Coimbra S, Catarino C, Costa E, Oliveira H, Figueiredo A, Rocha-Pereira P, et al.
Br J Dermatol . 2013 Nov; 170(4):939-42. PMID: 24245854
Background: Inflammation has a key role in the pathogenesis of psoriasis. Circulating cell-free DNA (CFD) is a marker of tissue cell damage closely associated with inflammation. Objectives: We aimed to...
7.
Silva F, Oliveira H, Moreiras A, Fernandes J, Bronze-da-Rocha E, Figueiredo A, et al.
Mutat Res . 2013 Mar; 753(1):42-7. PMID: 23474391
Acitretin is currently used alone or combined with PUVA (psoralen + UVA) or with narrow-band ultraviolet B (NBUVB), to treat moderate and severe psoriasis. However, little is known about the...
8.
Silva F, Oliveira H, Moreiras A, Fernandes J, Bronze-da-Rocha E, Figueiredo A, et al.
Toxicol In Vitro . 2013 Jan; 27(2):900-7. PMID: 23318729
Isotretinoin is a retinoic acid frequently used in monotherapy or combined with narrow-band ultraviolet B (NBUVB) irradiation to treat patients with acne and psoriasis vulgaris. As both diseases need frequent...
9.
Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al.
Br J Dermatol . 2010 Aug; 163(6):1282-90. PMID: 20716219
Background: Several cross-sectional studies have shown that different cytokines and growth factors are enhanced in psoriasis. Objectives: We aimed to understand the role/relation of interleukin (IL)-22, IL-17, IL-23, IL-8, vascular...
10.
Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al.
J Eur Acad Dermatol Venereol . 2010 Mar; 24(12):1386-94. PMID: 20337818
Background: Psoriasis vulgaris is associated with overweight/obesity and with increased C-reactive protein (CRP), tumour necrosis factor (TNF)-α, interleukin (IL)-6, leptin and resistin levels and decreased adiponectin levels. Objectives: To understand...